Biondi-Zoccai, Giuseppe
Mahajan, Arjun
Powell, Dylan
Peruzzi, Mariangela
Carnevale, Roberto
Frati, Giacomo
Article History
Received: 13 March 2025
Accepted: 8 April 2025
First Online: 5 May 2025
Competing interests
: Giuseppe Biondi-Zoccai has consulted, lectured and/or served as advisory board member for Abiomed, Advanced Nanotherapies, Aleph, Amarin, AstraZeneca, Balmed, Cardionovum, Cepton, Crannmedical, Endocore Lab, Eukon, Guidotti, Innovheart, Meditrial, Menarini, Microport, Opsens Medical, Synthesa, Terumo, and Translumina, outside the present work. The other authors declare no competing interests.